Pantoprazole DR
Closed Solicitation Posted
- Solicitation number
- SPE2D2-26-R-0010
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain seeks offers for Pantoprazole DR tablets through the Pharmaceutical Prime Vendor Program, with proposals due August 3 at 3:00 PM EST. This is a lowest-price technically acceptable firm-fixed-price requirements contract with a one-year base period and four option years (maximum five-year duration).
The procurement covers three line items: Pantoprazole DR 40 MG Tablets in 90-count bottles (36,219 estimated annual units), Pantoprazole DR 40 MG Tablets in 1000-count bottles (51,043 units), and Pantoprazole DR 20 MG Tablets in 90-count bottles (108,488 units). Products will supply the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through established PPV contractors. NAICS code is 325412, Pharmaceutical Preparation Manufacturing; PSC is 6505, Drugs and Biologicals.
Contractors must achieve performance readiness within 45 calendar days of award and deliver complete orders within 15 calendar days of receipt. All products must include bar code labeling at unit-of-use level conforming to GS1-128 or HIBCC standards, carry FDA approval documentation, and comply with current Good Manufacturing Practices (cGMP) at manufacturing facilities. Contractors must establish business-to-business agreements with each DLA and VA PPV contractor and embed a 0.5 percent cost recovery fee in all pricing, submitted quarterly. Large business offerors must submit a subcontracting plan. Offerors submit two volumes via DIBBS: Volume 1 includes SF 1449, trade agreements certification, representations, subcontracting plans, manufacturer letters of commitment and certification, and FDA violation disclosures; Volume 2 contains price proposals exclusive of Federal Excise Tax. Amendment 0001, issued July 1, revises missing information and specifies requirements are for Department of Work only; acknowledgment of amendment receipt is required prior to the offer deadline.
Notice text
2 versions
Update #2 · Latest ·
Amendment 0001 included to revise missing information from the solicitation and to inform offerorers that requirements are for DoW use only.
Update #1 ·
Pantoprazole DR Solicitation Attached.
Files
| File | Type | Posted |
|---|---|---|
| SF30_SPE2D226R00100001.PDF | ||
| Revised Final Solicitation - SPE2D2-26-R-0010.pdf | ||
| Final Solicitation - SPE2D2-26-R-0010.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Pantoprazole DR | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity